|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/33 | |
| A61K 31/34 | |||
| C07C 15/14 |
| (11) | Number of the document | 3102198 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15745823.3 |
| Date of filing the European patent application | 2015-02-03 | |
| (97) | Date of publication of the European application | 2016-12-14 |
| (45) | Date of publication and mention of the grant of the patent | 2020-08-26 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2015/014153 |
| Date | 2015-02-03 |
| (87) | Number | WO 2015/119899 |
| Date | 2015-08-13 |
| (30) | Number | Date | Country code |
| 201461936597 P | 2014-02-06 | US |
| (72) |
CHOBANIAN, Harry, US
DEMONG, Duane, US
GUO, Yan, US
HU, Zhiyong, US
MILLER, Michael, US
PIO, Barbara, US
PLUMMER, Christopher, W., US
XIAO, Dong, US
YANG, Cangming, US
ZHANG, Rui, US
|
| (73) |
Merck Sharp & Dohme Corp.,
126 East Lincoln Avenue, Rahway, NJ 07065-0907,
US
|
| (54) | ANTIDIABETIC COMPOUNDS |
| ANTIDIABETIC COMPOUNDS |